News
LL-37: Immunity, Microbial Defense, and Regenerative Research
LL-37, a 37-amino acid peptide derived from the cathelicidin antimicrobial peptide precursor hCAP18, has emerged as a molecule of considerable research interest. Encoded by...
Clinical Trials
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials,...
Interviews
Improving Lab Efficiency Through Equipment Utilization
Q1: How can pharmaceutical laboratories quantify the financial impact when it comes to underutilized equipment in today’s constrained economic environment? What are the steps...
Production & Manufacturing
End-To-End Solutions in Pharma Logistics Creating Difference
There is no shred of doubt that every stage of the pharmaceutical supply chain happens to be critical if the life-saving drugs are to...
Press Releases
GREENFIELD GLOBAL TAPS INDUSTRY VETERAN VEY GAROFALO TO DRIVE SPECIALTY CHEMICALS AND INGREDIENTS EXPANSION
Accomplished industry leader to continue driving growth and product expansion across life sciences, flavors, fragrances, and specialty segments
Greenfield Global Inc., a leading global producer,...
Articles
Energy efficiency in pure steam generation: How small adjustments can lead to big savings
Pharmaceutical manufacturers face a twofold challenge. They not only have to produce vital medicines faster and more efficiently. They must also reduce energy and...
Business & Industry
Sino BioPharm to Acquire LaNova Medicines for $950.9 M Deal
LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read